IP Library Granted Patent US 10,478,526
Granted Patent B2
US 10,478,526 · App. 14/888,613 · Granted Nov 19, 2019

Skin substitutes and methods for hair follicle neogenesis

Inventors: Rajesh Thangapazham (Rockville, MD); Thomas N. Darling (Rockville, MD); Shaowei Li (Potomac, MD)
Assignee: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
A61L27/3886A61L27/24A61L27/3804A61L27/3813A61L27/60A61L2430/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,478,526
App. No.
14/888,613
Granted
Nov 19, 2019
Kind
B2
Abstract

This invention provides compositions in the form of skin substitutes comprising epithelial cells and mesenchymal cells, wherein the mesenchymal cells are not isolated from the occipital or nape region of the scalp, as well as methods for using the same.

Claims (14)

1. A skin substitute comprising, in a suspension,

(i) epithelial cells; and

(ii) isolated mesenchymal cells that are derived from the temporal region of a scalp, wherein the skin substitute induces hair follicle neogenesis.

2. The skin substitute of claim 1 , wherein the skin substitute is provided in a microsphere.

3. The skin substitute of claim 1 , wherein the suspension comprises a matrix.

4. The skin substitute of claim 3 , wherein the matrix is a collagen matrix.

5. The skin substitute of claim 1 , wherein the isolated mesenchymal cells are hair follicle dermal cells.

6. The skin substitute of claim 5 , wherein the hair follicle dermal cells are neural crest-derived cells, dermal papilla cells, or dermal sheath cells.

7. The skin substitute of claim 1 , wherein the epithelial cells are keratinocytes.

8. The skin substitute of claim 1 , wherein the epithelial cells are from a first or second passage and/or the isolated mesenchymal cells are from a first, second, third, or fourth passage.

9. The skin substitute of claim 1 , wherein the epithelial cells and the isolated mesenchymal cells are passaged in keratinocyte-conditioned medium.

10. The skin substitute of claim 1 , wherein the epithelial cells and the isolated mesenchymal cells are human.

11. The skin substitute of claim 1 , wherein the isolated mesenchymal cells are genetically unmodified mesenchymal cells.

12. A method for inducing hair follicle neogenesis, comprising delivering the skin substitute of claim 1 to a human subject, wherein the human subject has partial-thickness skin loss, full-thickness skin loss, a wound, a burn, a scar, or hair loss.

Assignments (1)
CONFIRMATORY LICENSE Recorded Oct 3, 2016
From: HENRY M. JACKSON FDN FOR THE ADV MIL/MED
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039921/0276 →
Continuity (2)
Provisional Application 61819332 · May 3, 2013
Related Publication 20160184481A1 · Jun 30, 2016